Health Monitor Monaco: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Monitor Monaco.

Press releases published on October 30, 2026

2 hours ago

Why Kraig Labs’ Spider Silk Could Have a Future in Aerospace

Indeterminate GlobeNewswire

2 hours ago

NeOnc’s Ambitious Brain Cancer Plans are Setting the Stage

Indeterminate GlobeNewswire

2 hours ago

Pelthos Therapeutics to Combine with Castle Creek Biosciences, Creating Transformative Biotechnology Company Focused on Serious Diseases that Affect the Skin

Indeterminate GlobeNewswire

2 hours ago

Akari Therapeutics to Highlight Novel RNA-Splicing ADC Payload Strategy at the 3rd Annual ADC Payload Summit

Indeterminate GlobeNewswire

2 hours ago

Syndax’s Revuforj® (revumenib) Wins Prestigious 2026 Prix Galien USA Award for Best Product for Rare/Orphan Diseases

Indeterminate GlobeNewswire

2 hours ago

Press Release Biocartis NV: Biocartis to Present Initial Development Data for Ultra-Rapid Idylla™ Breast21 Assay at SABCS 2026

Indeterminate GlobeNewswire

2 hours ago

Alps Group Inc Announces Shareholder Approval for a Share Consolidation, Share Capital Increase, and Adoption of Second Amended and Restated Memorandum and Articles of Association

Indeterminate GlobeNewswire

2 hours ago

Femasys Appoints John Moorhead to Board of Directors

Indeterminate GlobeNewswire

2 hours ago

BioNexus Launches New Corporate Website with Expanded Business and Investor Resources

Indeterminate GlobeNewswire

2 hours ago

Atsena Therapeutics Reports New Preclinical Data Demonstrating Robust MYO7A Expression and Favorable Safety for ATSN-301, a Laterally Spreading Dual AAV Vector-based Gene Therapy for Usher Syndrome Type 1B

Indeterminate GlobeNewswire

3 hours ago

Moleculin Completes Dosing Patients in Part A of Pivotal MIRACLE Trial; Comprehensive Data Readout on Track for Q1 2027

Indeterminate GlobeNewswire

3 hours ago

CDT Equity Welcomes U.S. Regulatory Development Supporting Expanded Access to Compounded Peptides

Indeterminate GlobeNewswire

3 hours ago

Daré Bioscience Surpasses $43 Million in Non-Dilutive Grant Funding as Investigational Programmable Drug Delivery Platform Gains Momentum

Indeterminate GlobeNewswire

3 hours ago

Werewolf Therapeutics Selected for Oral Presentation and to Present Posters at the Society for Immunotherapy of Cancer’s (SITC) 2026 Annual Meeting

Indeterminate GlobeNewswire

3 hours ago

Integra LifeSciences to Highlight Hands-On Education and Neurosurgery Innovation at CNS 2026 Annual Meeting

Indeterminate GlobeNewswire

3 hours ago

IRADIMED CORPORATION Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

3 hours ago

Sienna Completes Acquisition in Ottawa

Indeterminate GlobeNewswire

3 hours ago

Propanc Biopharma Advances Bioanalytical & Immunogenicity Assay Development for Phase 1b First-In-Human Study in up to 50 Advanced Cancer Patients

Indeterminate GlobeNewswire

3 hours ago

NurExone Demonstrates Consistent Anti-Inflammatory Activity Across Three Separate Batches of Exosomes

Indeterminate GlobeNewswire

3 hours ago

Polk County Mosquito Control Reduces Aedes aegypti by Up to 95% with Sterile Insect Farms™ Sterile Male Releases

Indeterminate GlobeNewswire